# Tumor-Specific T-Cells (cCTL:GL01) for Advanced Gastrointestinal Cancer

> clinical trial · VERIFIED · 2026-07-29

Status: NOT_YET_RECRUITING · Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Condition: Advanced Gastrointestinal Cancer

- Company: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07735065

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.